key: cord-0876419-xumhhmb7
authors: Bittmann, Stefan
title: Role of Omicron variant of SARS-CoV-2 in children in Germany
date: 2022-02-01
journal: World J Pediatr
DOI: 10.1007/s12519-021-00511-3
sha: b0141444f2a3439e79a10ce94878081fa459abf3
doc_id: 876419
cord_uid: xumhhmb7

nan

A new variant of SARS-CoV-2, B.1.1.529 was first reported by the South African Department of Health on Nov 24, 2021. This new variant was named as B.1.1.529 Omicron and was classified as a variant of concern (VOC) by the World Health Organization (WHO) on Nov 26, 2021 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Phylogenetic studies showed that Omicron arose independently of the currently dominant delta variant. It has an unusually high number of approximately 30 changes of amino acids in the spike protein compared with the original SARS-CoV-2, including those with known phenotypic impact (increase in transmission, immune evasion, and transmissibility), but significances of many mutations are still unclear [4] [5] [6] [7] . The variant has already been detected in several countries worldwide, including Germany [2, 3] So far, the Omicron variant is not known to be more contagious. The number of infected persons and thus also of children will increase dramatically. However, it is not yet clear whether Omicron also leads more frequently to severe courses of disease [1-13]. If Omicron makes people less ill, it is possible that more children will be hospitalized than is the case now simply because of the high number of infected cases. The statement by Health Minister Karl Lauterbach of Germany that "the Omicron variant is particularly dangerous for children and would lead to high hospitalization rates" is obviously not supported by facts. Lauterbach is apparently referring to a study from South Africa and its reception in Indian media. According to the virologist Klaus Stöhr, with whom the Berliner Zeitung spoke on the subject, the study was pre-published on Dec. 5 and then excerpts were also presented at a meeting of the World Health Organization (WHO) on Dec. 7. WHO announced that Omicron is spreading, but the number of severe cases in South Africa remains low. The very limited data from the study would suggest that the course of the disease may well be milder. This is concluded because very many patients, including many children and adolescents, tested positive for corona only at the hospital on admission but were actually admitted for other reasons. The New York Times reported that the proportion of asymptomatic and mild disease was, therefore, apparently much higher than that in previous waves, according to the initial observations. The portrayal that children were being affected by Omicron misses the data. The Indian media are also very cautious about drawing conclusions. The current data worldwide do not yet say anything reliable about the dangerousness of the variant or the degree of hospitalization. The medical treatment seems not extraordinary different from Covid-19. Oxygen, interleukin-6 inhibitors, JAK inhibitors and other therapies should also play an important role as treatment options.

Omicron is a new viral variant with an unpredictable outcome. Time will show further severity in the pediatric population.

The effects of the silence on south African children and adolescents against a global alert on the newly identified coronavirus variant: Omicron

Omicron emerges

Omicron: a speculation on its potential superpowers

Where did "weird" Omicron come from? Science

Division of Viral Diseases. CDC COVID-19 Science Briefs

Centers for Disease Control and Prevention (US); 2020. Science Brief: Omicron (B.1.1.529) Variant

Omicron SARS-CoV-2 variant: What we know and what we don't

OMICRON (B.1.1.529): a new SARS-CoV-2 Variant of Concern mounting worldwide fear

Omicron: a drug developer's perspective. Emerg Microbes Infect

How severe are Omicron infections?

Omicron sparks a vaccine strategy debate

Audio interview: the Omicron variant of SARS-CoV-2

Covid-19: Omicron and the need for boosters